Your browser doesn't support javascript.
loading
Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19.
Hottz, Eugenio D; Martins-Gonçalves, Remy; Palhinha, Lohanna; Azevedo-Quintanilha, Isaclaudia G; de Campos, Mariana M; Sacramento, Carolina Q; Temerozo, Jairo R; Soares, Vinicius Cardoso; Dias, Suelen S Gomes; Teixeira, Lívia; Castro, Ícaro; Righy, Cassia; Souza, Thiago Moreno L; Kurtz, Pedro; Andrade, Bruno B; Nakaya, Helder I; Monteiro, Robson Q; Bozza, Fernando A; Bozza, Patrícia T.
Afiliación
  • Hottz ED; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Martins-Gonçalves R; Laboratory of Immunothrombosis, Department of Biochemistry, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Brazil.
  • Palhinha L; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Azevedo-Quintanilha IG; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • de Campos MM; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Sacramento CQ; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Temerozo JR; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Soares VC; Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Dias SSG; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Teixeira L; Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Castro Í; Laboratory on Thymus Research, and.
  • Righy C; National Institute for Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
  • Souza TML; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Kurtz P; Immunology and inflammation (IMPPG), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
  • Andrade BB; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Nakaya HI; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Monteiro RQ; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
  • Bozza FA; Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil.
  • Bozza PT; National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Blood Adv ; 6(17): 5085-5099, 2022 09 13.
Article en En | MEDLINE | ID: mdl-35420680
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Trombofilia / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Brasil
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Trombofilia / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Brasil